Literature DB >> 18579201

Impact of gestational cocaine treatment or prenatal cocaine exposure on early postpartum oxytocin mRNA levels and receptor binding in the rat.

M S McMurray1, E T Cox, T M Jarrett, S K Williams, C H Walker, J M Johns.   

Abstract

Prior research reported decreased oxytocin levels in specific brain regions correlated with disruptions in maternal care following gestational cocaine treatment in rats. Similarly, prenatal exposure to cocaine impaired subsequent maternal behavior in adulthood, but behavioral alterations were not associated with decreases in oxytocin levels in the same brain regions as were found in their cocaine-treated rat dams. To determine if other aspects of the oxytocin system are disrupted by cocaine treatment or prenatal exposure to cocaine during critical time points associated with maternal care, oxytocin mRNA transcription and receptor binding were examined on postpartum day two in relevant brain regions following gestational treatment with, or prenatal exposure to, either cocaine or saline. We hypothesized that oxytocin mRNA levels and receptor binding would be differentially affected by cocaine in the early postpartum period of dams and their offspring. Our findings indicate that gestational cocaine treatment resulted in significant increases in oxytocin mRNA levels in only the paraventricular nucleus of cocaine-treated dams, with almost significant increases in both generations in the supraoptic nucleus, but no significant effects of cocaine on receptor binding in either generation of dams. These findings indicate that in addition to oxytocin levels, cocaine treatment or prenatal exposure primarily affects oxytocin mRNA synthesis, with little effect on receptor binding in specific brain regions associated with maternal behavior in the early postpartum period of the rat.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579201      PMCID: PMC2614125          DOI: 10.1016/j.npep.2008.05.003

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  94 in total

1.  Effects of dopamine receptor antagonists on ongoing maternal behavior in rats.

Authors:  M R Silva; M M Bernardi; L F Felicio
Journal:  Pharmacol Biochem Behav       Date:  2001-03       Impact factor: 3.533

2.  Acute cocaine alters oxytocin levels in the medial preoptic area and amygdala in lactating rat dams: implications for cocaine-induced changes in maternal behavior and maternal aggression.

Authors:  J C Elliott; D A Lubin; C H Walker; J M Johns
Journal:  Neuropeptides       Date:  2001-04       Impact factor: 3.286

3.  Control of synthesis and release of oxytocin in the sheep brain.

Authors:  K M Kendrick; E B Keverne
Journal:  Ann N Y Acad Sci       Date:  1992-06-12       Impact factor: 5.691

4.  Atlas of the neurons that express mRNA for the long form of the prolactin receptor in the forebrain of the female rat.

Authors:  J C Bakowska; J I Morrell
Journal:  J Comp Neurol       Date:  1997-09-22       Impact factor: 3.215

5.  PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys.

Authors:  Michael A Nader; Drake Morgan; H Donald Gage; Susan H Nader; Tonya L Calhoun; Nancy Buchheimer; Richard Ehrenkaufer; Robert H Mach
Journal:  Nat Neurosci       Date:  2006-07-09       Impact factor: 24.884

6.  Hippocampal lesions disrupt maternal, not sexual, behavior in the albino rat.

Authors:  D P Kimble; L Rogers; C W Hendrickson
Journal:  J Comp Physiol Psychol       Date:  1967-06

7.  Reduced serotonin release and serotonin uptake sites in the rat nucleus accumbens and striatum after prenatal cocaine exposure.

Authors:  Qing Shan Yan
Journal:  Brain Res       Date:  2002-03-01       Impact factor: 3.252

8.  Oxytocin and vasopressin secretion in monkeys administered apomorphine and a D2 receptor agonist.

Authors:  J A Amico; L M Layden; S M Pomerantz; J L Cameron
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

9.  Developmental effects of prenatal cocaine exposure on 5-HT1A receptors in male and female rat offspring.

Authors:  Josephine M Johns; Deborah A Lubin; Jeffrey A Lieberman; Jean M Lauder
Journal:  Dev Neurosci       Date:  2002       Impact factor: 2.984

10.  Effect of progesterone on hypothalamic oxytocin messenger ribonucleic acid levels in the lactating rat.

Authors:  A Thomas; R S Crowley; J A Amico
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

View more
  6 in total

1.  Cocaine alters dendritic spine density in cortical and subcortical brain regions of the postpartum and virgin female rat.

Authors:  Maya Frankfurt; Kaliris Salas-Ramirez; Eitan Friedman; Victoria Luine
Journal:  Synapse       Date:  2011-04-07       Impact factor: 2.562

Review 2.  Prenatal and gestational cocaine exposure: Effects on the oxytocin system and social behavior with implications for addiction.

Authors:  S K Williams; J M Johns
Journal:  Pharmacol Biochem Behav       Date:  2013-07-21       Impact factor: 3.533

3.  Prenatal cocaine exposure: the role of cumulative environmental risk and maternal harshness in the development of child internalizing behavior problems in kindergarten.

Authors:  Rina D Eiden; Stephanie Godleski; Craig R Colder; Pamela Schuetze
Journal:  Neurotoxicol Teratol       Date:  2014-05-04       Impact factor: 3.763

4.  Early postpartum pup preference is altered by gestational cocaine treatment: associations with infant cues and oxytocin expression in the MPOA.

Authors:  E T Cox Lippard; T M Jarrett; M S McMurray; P S Zeskind; K A Garber; C R Zoghby; K Glaze; W Tate; J M Johns
Journal:  Behav Brain Res       Date:  2014-10-06       Impact factor: 3.332

5.  Social behavior of offspring following prenatal cocaine exposure in rodents: a comparison with prenatal alcohol.

Authors:  Sonya K Sobrian; R R Holson
Journal:  Front Psychiatry       Date:  2011-11-30       Impact factor: 4.157

6.  Effects of cocaine on maternal behavior and neurochemistry.

Authors:  Benjamin C Nephew; Marcelo Febo
Journal:  Curr Neuropharmacol       Date:  2012-03       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.